Companies › ZYME

ZYMEWORKS INC (ZYME)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001937653 · EDGAR filings · Updated 2026-07-06

ZYMEWORKS INC (ZYME) has reported institutional ownership of 95.3%, with 211 institutional managers holding positions valued at $1.76B per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Latest updates

• 2026-07-06 — Insider transaction reported (Form 4)
• 2026-06-29 — Current report (8-K) filed
• 2026-05-15 — Insider transaction reported (Form 4)
• 2026-05-15 — Initial insider ownership filed (Form 3)
• 2026-05-15 — SCHEDULE 13G/A filed
• 2026-05-14 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ZYMEWORKS INC has 211 institutional holders and institutional ownership of 95.3%.

Insider activity

Insiders reported 33 transactions (9 buys, 10 sells) across 11 reporting insiders, with a net reported value of $2.54M.

Data flags from SEC filings

Related companies

VERICEL CORP COM (VCEL) · OCULAR THERAPEUTIX INC (OCUL) · PEDIATRIX MEDICAL GROUP INC (MD) · INNOVIVA INC (INVA) · LEGEND BIOTECH CORP (LEGN) · UFP TECHNOLOGIES INC (UFPT)